Kim De Keersmaecker

22PUBLICATIONS
86CO-AUTHORS
Haematological tumoursGene expression (incl. microarray and other genome-wide approaches)Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (22)

|Jun 08, 2026
A RiboCancer cell line panel reveals that CLL-associated Rps15 mutations translationally rewire transcription through codon-specific tRNA accommodation defects.

|Nov 24, 2025
To be or not to be a protein coding mutation, that's the question!

Dylan De Groote, Daniele Pepe, Xander Janssens

|May 28, 2025
HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in T-cell leukemia.

Jonas De Kesel, Igor Fijalkowski, Tim Pieters

|Mar 06, 2025
Ribosome specialization by cancer-associated ribosomal protein mutations: progress made and open questions.

Marino Caruso, Kim De Keersmaecker

|Nov 13, 2024
Sertraline/chloroquine combination therapy to target hypoxic and immunosuppressive serine/glycine synthesis-dependent glioblastomas.

Anaís Sánchez-Castillo, Kim G Savelkouls, Alessandra Baldini

|Feb 12, 2024
Correction: Targeting serine/glycine metabolism improves radiotherapy response in non-small cell lung cancer.

Anaís Sánchez-Castillo, Elien Heylen, Judith Hounjet

Pageof 4

Frequent Collaborators

6 joint publications

Stijn Vereecke

6 joint publications

Kim Rosalie Kampen

5 joint publications

Elien Heylen

3 joint publications

Jan Cools